UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 398

Sortiert nach

Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations

American journal of hematology, 2024-06, Vol.99 (6), p.1196-1200

2024

Link zum Volltext

Verfügbarkeit prüfen

An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma

European journal of haematology, 2015-11, Vol.95 (5), p.426-435

2015

Link zum Volltext

Verfügbarkeit prüfen

Genesis of the structural pathology of myelinated fibers in median nerve entrapment

Muscle & nerve, 2012-12, Vol.46 (6), p.970-977

Ochoa, José L.

2012

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

British journal of haematology, 2012-06, Vol.157 (5), p.553-563

2012

Link zum Volltext

Verfügbarkeit prüfen

Neuropathic Pain Syndrome Displayed by Malingerers

The journal of neuropsychiatry and clinical neurosciences, 2010-07, Vol.22 (3), p.278-286

2010

Link zum Volltext

Verfügbarkeit prüfen

Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy

Muscle & nerve, 2005-10, Vol.32 (4), p.459-472

2005

Link zum Volltext

Verfügbarkeit prüfen

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?

Case reports in transplantation, 2012-01, Vol.2012, p.942795-4

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-12, Vol.11 (24), p.8728-8736

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience

Clinical lymphoma, myeloma and leukemia, 2011-12, Vol.11 (6), p.507-511

2011

Link zum Volltext

Verfügbarkeit prüfen

Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats

Revista de investigacion clinica, 2009-05, Vol.61 (3), p.212

2009

Link zum Volltext

Verfügbarkeit prüfen

Three‐drug versus two‐drug induction therapy regimens for patients with transplant‐eligible multiple myeloma

Cochrane database of systematic reviews, 2016-10, Vol.2016 (10)

2016

Link zum Volltext

Verfügbarkeit prüfen

Neuropathic pain syndrome displayed by malingerers

The journal of neuropsychiatry and clinical neurosciences, 2010-01, Vol.22 (3), p.278-286

2010

Link zum Volltext

Verfügbarkeit prüfen

Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes

Annals of neurology, 1993-05, Vol.33 (5), p.465-472

1993

Link zum Volltext

Verfügbarkeit prüfen

Impact of doxycycline on outcomes in AL amyloidosis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20568-e20568

2020

Link zum Volltext

Verfügbarkeit prüfen

Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8517-8517

2020

Link zum Volltext

Verfügbarkeit prüfen

Updated Outcomes of Fludarabine/Melphalan/Bortezomib (Flu/Mel/Vel) Conditioning for Upfront Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.5885-5885

2016

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetics and Clinical Outcomes of Plasma Cell Leukemia Patients: A Single Institution Experience

Blood, 2009-11, Vol.114 (22), p.4932-4932

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Bortezomib(Bz), Pegylated Doxorubicin(DOX) and Dexamethasone(dex); ( VDD) with Escalating Doses of Cyclophosphamide(Cy) in Patients with Newly Diagnosed Myeloma

Blood, 2009-11, Vol.114 (22), p.617-617

2009

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Blood, 2014-12, Vol.124 (21), p.3987-3987

2014

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning For Consolidation Of VGPR Or CR In Myeloma

Blood, 2013-11, Vol.122 (21), p.3390-3390

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with solitary plasmacytomas (SP) in the era of PET imaging and serum-free light chain (sFLC) testing: A single institution experience

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8608-8608

2013

Link zum Volltext

Verfügbarkeit prüfen

Apheresis of Hematopoietic Progenitor Cell (HPC) From Allogeneic Donors ≥60 Years of Age

Blood, 2009-11, Vol.114 (22), p.4226-4226

2009

Link zum Volltext

Verfügbarkeit prüfen

Does HLA-C Matching Predict the Engrafting Unit in Double Umbilical Cord Blood Transplants?: A Single Institution Retrospective Analysis

Blood, 2014-12, Vol.124 (21), p.2475-2475

2014

Link zum Volltext

Verfügbarkeit prüfen

Beclomethasone and Budesonide Are Partially Effective As Sole Therapy for Isolated Gastro-Intestinal Gvhd

Blood, 2014-12, Vol.124 (21), p.2500-2500

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 398

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(330)
Mit Volltextzugriff
(362)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(212)
Life Sciences & Biomedicine
(165)
Humans
(98)
Male
(64)
Female
(58)
Animals
(45)
Middle Aged
(43)
Biological And Medical Sciences
(41)
Adult
(39)
Aged
(32)
Neurosciences & Neurology
(31)
Physical Sciences
(30)
Clinical Neurology
(24)
Medical Sciences
(24)
Technology
(24)
Chemistry
(21)
Neurosciences
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Medicine, General & Internal
(17)
Computer Science
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations

An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma

Genesis of the structural pathology of myelinated fibers in median nerve entrapment

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

Neuropathic Pain Syndrome Displayed by Malingerers

Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?

Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors

Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience

Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats

Three‐drug versus two‐drug induction therapy regimens for patients with transplant‐eligible multiple myeloma

Neuropathic pain syndrome displayed by malingerers

Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypes

Impact of doxycycline on outcomes in AL amyloidosis

Will adding alkylating agent to bortezomib improve survival of newly diagnosed AL amyloidosis patients?

Updated Outcomes of Fludarabine/Melphalan/Bortezomib (Flu/Mel/Vel) Conditioning for Upfront Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Cytogenetics and Clinical Outcomes of Plasma Cell Leukemia Patients: A Single Institution Experience

Phase I Study of Bortezomib(Bz), Pegylated Doxorubicin(DOX) and Dexamethasone(dex); ( VDD) with Escalating Doses of Cyclophosphamide(Cy) in Patients with Newly Diagnosed Myeloma

A Phase 2 Study of High-Dose Melphalan Plus Bortezomib (Mel/Vel) Conditioning Followed By Autologous Hematopoietic Cell Transplantation in Myeloma

Allogeneic Hematopoietic Cell Transplantation Using Fludarabine, Melphalan and Bortezomib (Flu/Mel/Vel) Conditioning For Consolidation Of VGPR Or CR In Myeloma

Outcomes of patients with solitary plasmacytomas (SP) in the era of PET imaging and serum-free light chain (sFLC) testing: A single institution experience

Apheresis of Hematopoietic Progenitor Cell (HPC) From Allogeneic Donors ≥60 Years of Age

Prolonged Sirolimus Administration after Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplantation Is Associated with Decreased Risk for Moderate-Severe Chronic Graft Vs. Host Disease

Does HLA-C Matching Predict the Engrafting Unit in Double Umbilical Cord Blood Transplants?: A Single Institution Retrospective Analysis

Beclomethasone and Budesonide Are Partially Effective As Sole Therapy for Isolated Gastro-Intestinal Gvhd

Aktive Filter

Suchergebnisse filtern